Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AHRQ Brain Tumor MRS Tech Assessment Makes NCD Reversal Doubtful

This article was originally published in The Gray Sheet

Executive Summary

The limited availability of magnetic resonance spectroscopy (MRS) for diagnosing brain tumors has made it difficult to pursue the types of large clinical trials necessary for obtaining national coverage, according to an 1AHRQ tech assessment

You may also be interested in...



CMS Aims To Clarify Diagnostic Imaging National Coverage Approach

CMS will develop industry-specific draft guidance documents covering sectors such as durable medical equipment and imaging devices, according to CMS Lead Medical Officer Carlos Cano, MD

CMS Aims To Clarify Diagnostic Imaging National Coverage Approach

CMS will develop industry-specific draft guidance documents covering sectors such as durable medical equipment and imaging devices, according to CMS Lead Medical Officer Carlos Cano, MD

CMS Non-Coverage Ruling Delay Apt If Device Lacks Evidence – AdvaMed

CMS should defer to local carriers when an absence of data prevents the agency from discerning whether an item or service meets the standard for "reasonable and necessary," AdvaMed contends

Related Content

UsernamePublicRestriction

Register

LL1132440

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel